Skip to content

G&A at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$26.2M+85.4%
Sutro Biopharma logo
Sutro BiopharmaSTRO
$7.58M-42.9%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$38.95M-11.1%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$5.89M+1.0%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$14.09M-6.0%
Sana Biotechnology logo
Sana BiotechnologySANA
$11.46M-0.2%

Segments

By segment

See full
Reportable Segment$553M+9.5%

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$153.76B+13.9%
Enterprise value$168.3B+10.7%
P/E16.7×-5.9×
P/S5.2×+0.5×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Questions, answered.

What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.